Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:1341-1346
Published online before print May 30, 2002, doi: 10.1161/01.ATV.0000024082.46387.38
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
22/8/1341    most recent
01.ATV.0000024082.46387.38v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schiller, N. K.
Right arrow Articles by Curtiss, L. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schiller, N. K.
Right arrow Articles by Curtiss, L. K.
Related Collections
Right arrow Other Ethics and Policy
Right arrow CV surgery: aortic and vascular disease
Right arrow Endothelium/vascular type/nitric oxide
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:1341.)
© 2002 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Inflammation in Atherosclerosis

Lesion Formation in LDL Receptor–Deficient Mice With Perforin and Lystbeige Mutations

Natalie K. Schiller; William A. Boisvert; Linda K. Curtiss

From The Scripps Research Institute, Department of Immunology, La Jolla, Calif.

Reprint requests to Linda K. Curtiss, The Scripps Research Institute, Department of Immunology, IMM17, 10550 N Torrey Pines Rd, La Jolla, CA 92037. E-mail lcurtiss{at}scripps.edu

Objective— Natural killer (NK) cells have been identified in human vascular pathologies. In this study, we identified NK cells in aortic root atherosclerotic lesions of low density lipoprotein (LDL) receptor–deficient (LDLr-/-) mice. To characterize the role of NK cell–mediated cytolysis in atherosclerosis, we generated C57Bl/6 double-mutant mice by crossing LDLr-/- mice with NK cell–defective Lystbeige mice (creating beige,LDLr-/- mice) and with perforin-deficient mice (creating Pfp-/-,LDLr-/- mice).

Methods and Results— Male mice (8 to 10 weeks old) were fed a high-fat diet to induce atherosclerosis. Compared with LDLr-/- mice, beige,LDLr-/- mice had impaired NK cell cytolytic activity and significantly increased atherosclerosis (P<0.05). Pfp-/-,LDLr-/- mice had impaired NK cell cytolytic activity, yet they had lesions that were similar to those of control mice. This suggested that NK cell cytolysis did not play a significant role in atherosclerosis and that the exacerbated atherosclerosis of the beige,LDLr-/- mouse was independent of impaired NK cell cytolytic activity. Therefore, we investigated the role of T and B lymphocytes in atherosclerosis of beige mice by crossing them with recombinase activator gene 1–deficient LDLr-/- mice (Rag1-/-,LDLr-/- mice), thus creating beige,Rag1-/-, LDLr-/- mice. As in the double-mutant study, beige,Rag1-/-,LDLr-/- mice had significantly increased lesions compared with Rag1-/-,LDLr-/- control mice.

Conclusions— Therefore, the Lystbeige mutation in LDLr-/- mice has proatherogenic properties that are independent of NK cell–mediated cytolysis and lymphocyte-mediated acquired immunity.


Key Words: atherosclerosis • perforin • Chédiak-Higashi syndrome • lysosome • natural immunity




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
R. J. Petrovan, Y. Yuan, and L. K. Curtiss
Expression of the Lystbeige mutation is atheroprotective in chow-fed apolipoprotein E-deficient mice
J. Lipid Res., February 1, 2008; 49(2): 429 - 437.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
P. A. VanderLaan and C. A. Reardon
Thematic review series: The Immune System and Atherogenesis. The unusual suspects:an overview of the minor leukocyte populations in atherosclerosis
J. Lipid Res., May 1, 2005; 46(5): 829 - 838.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
G. S. Getz
Bridging the innate and adaptive immune systems
J. Lipid Res., April 1, 2005; 46(4): 619 - 622.
[Full Text] [PDF]


Home page
J. Lipid Res.Home page
N. K. Schiller, A. S. Black, G. P. Bradshaw, D. J. Bonnet, and L. K. Curtiss
Participation of macrophages in atherosclerotic lesion morphology in LDLr-/- mice
J. Lipid Res., August 1, 2004; 45(8): 1398 - 1409.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. F. Linton, A. S. Major, and S. Fazio
Proatherogenic Role for NK Cells Revealed
Arterioscler Thromb Vasc Biol, June 1, 2004; 24(6): 992 - 994.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. C. Whitman, D. L. Rateri, S. J. Szilvassy, W. Yokoyama, and A. Daugherty
Depletion of Natural Killer Cell Function Decreases Atherosclerosis in Low-Density Lipoprotein Receptor Null Mice
Arterioscler Thromb Vasc Biol, June 1, 2004; 24(6): 1049 - 1054.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. S. Getz
Do Natural Killer Cells Participate in a Killer Vascular Disease?
Arterioscler Thromb Vasc Biol, August 1, 2002; 22(8): 1251 - 1253.
[Full Text] [PDF]